Diabetologia 57 , 18121819 (2014)
Knowing what to expectand whengives you the confidence to stick with treatment
GLP-1 injections are a medication that has science and research backing their use for physician-assisted weight loss
The three targets are the GLP-1 receptor, the GIP receptor, and the glucagon receptor
The evidence for GLP-1 medications in treating NASH (the more severe form of fatty liver disease) is particularly impressive: Liraglutide achieved histological resolution of steatohepatitis in 39% of cases after 48 weeks, compared to just 9% in placebo groups 20 Patients taking liraglutide had 4.5 times higher likelihood of NASH resolution than those on placebo 20 Semaglutide demonstrated NASH resolution in 59% of participants versus 17% in placebo groups 21 We offer FibroScan technology to measure liver stiffness and fat content, helping us monitor your progress while on GLP-1 therapy
The irony is that some fermented foods, particularly those from cabbage like sauerkraut and kimchi, also contain sulfur compounds